Thauvin-Robinet C, Auclair M, Duplomb L, Caron-Debarle M, Avila M, St-Onge J, et al. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet. 2013;93(1):141–9.
Article PubMed PubMed Central CAS Google Scholar
Chudasama KK, Winnay J, Johansson S, Claudi T, König R, Haldorsen I, et al. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Am J Hum Genet. 2013;93(1):150–7.
Article PubMed PubMed Central CAS Google Scholar
Dyment DA, Smith AC, Alcantara D, Schwartzentruber JA, Basel-Vanagaite L, Curry CJ, et al. Mutations in PIK3R1 cause SHORT syndrome. Am J Hum Genet. 2013;93(1):158–66.
Article PubMed PubMed Central CAS Google Scholar
Gorlin RJ, Cervenka J, Moller K, Horrobin M, Witkop CJ. Malformation syndromes A selected miscellany. Birth Defects Orig Artic Ser. 1975;11(2):39–50.
Sensenbrenner JA, Hussels IE, Levin LS. A low birthweight syndrome, ? Rieger syndrome. Birth Defects Orig Artic Ser. 1975;11(2):423–6.
Avila M, Dyment DA, Sagen JV, St-Onge J, Moog U, Chung BHY, et al. Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: towards recommendation for molecular testing and management. Clin Genet. 2015. An important overview of a large case series with SHORT syndrome.
Innes AM, Dyment DA. SHORT Syndrome. 2014 May 15 [Updated 2020 Jun 4]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK201365/
Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133–223.
Article PubMed PubMed Central CAS Google Scholar
Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol. 2012;13(3):195–203. An excellent and in-depth perspective on the PI3K signaling pathway and its significance in humans.
Article PubMed CAS Google Scholar
Aubin D, Gagnon A, Sorisky A. Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. Int J Obes. 2005;29(8):1006–9.
Huang-Doran I, Tomlinson P, Payne F, Gast A, Sleigh A, Bottomley W, et al. Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations. JCI Insight. 2016;1(17):e88766.
Article PubMed PubMed Central Google Scholar
Kushi R, Hirota Y, Ogawa W. Insulin resistance and exaggerated insulin sensitivity triggered by single-gene mutations in the insulin signaling pathway. Diabetol Int. 2021;12(1):62–7. An interesting overview which provides insight on SHORT syndrome as being primarily an insulin resistance syndrome.
Ogawa W, Araki E, Ishigaki Y, Hirota Y, Maegawa H, Yamauchi T, et al. New classification and diagnostic criteria for insulin resistance syndrome. Endocr J. 2022;69(2):107–13.
Article PubMed CAS Google Scholar
Kwok A, Zvetkova I, Virtue S, Luijten I, Huang-Doran I, Tomlinson P, et al. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure. Mol Metab. 2020;40:101020. An important study that provides insight to the specific pathogenesis of SHORT syndrome which differentiates it from other forms of lipodystrophies.
Article PubMed PubMed Central CAS Google Scholar
Ortega-Molina A, Efeyan A, Lopez-Guadamillas E, Muñoz-Martin M, Gómez-López G, Cañamero M, et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab. 2012;15(3):382–94.
Article PubMed CAS Google Scholar
Gomez-Hernandez A, Lopez-Pastor AR, Rubio-Longas C, Majewski P, Beneit N, Viana-Huete V, et al. Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet-induced obesity and its metabolic complications in male mice. Mol Metab. 2020;31:1–13.
Article PubMed CAS Google Scholar
Solheim MH, Winnay JN, Batista TM, Molven A, Njølstad PR, Kahn CR. Mice carrying a dominant-negative human PI3K mutation are protected from obesity and hepatic steatosis but not diabetes. Diabetes. 2018;67(7):1297–309.
Article PubMed PubMed Central CAS Google Scholar
Winnay JN, Solheim MH, Dirice E, Sakaguchi M, Noh H-L, Kang HJ, et al. PI3-kinase mutation linked to insulin and growth factor resistance in vivo. J Clin Invest. 2016;126(4):1401–12. An important study in a mouse model on the effects of PI3K mutations in different systems.
Article PubMed PubMed Central Google Scholar
Restuccia DF, Hynx D, Hemmings BA. Loss of PKBβ/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo. Dis Model Mech. 2012;5(3):403–11.
PubMed PubMed Central CAS Google Scholar
Gherzi R, Trabucchi M, Ponassi M, Gallouzi IE, Rosenfeld MG, Briata P. Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ. 2010;17(6):975–83.
Article PubMed CAS Google Scholar
Mukherjee A, Rotwein P. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol Endocrinol. 2008;22(5):1238–50.
Article PubMed PubMed Central CAS Google Scholar
Prontera P, Micale L, Verrotti A, Napolioni V, Stangoni G, Merla G. A new homozygous IGF1R variant defines a clinically recognizable incomplete dominant form of SHORT syndrome. Hum Mutat. 2015;36(11):1043–7.
Article PubMed CAS Google Scholar
Alcantara D, Elmslie F, Tetreault M, Bareke E, Hartley T, Care4Rare Consortium, et al. SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase Cɛ) impairing TORC2-dependent AKT activation. Hum Mol Genet. 2017 Oct 1;26(19):3713–3721.
Ranza E, Guimier A, Verloes A, Capri Y, Marques C, Auclair M, et al. Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants. Clin Genet. 2020;98(1):10–8. On the newly recognized overlap between Noonan syndrome and SHORT syndrome.
Article PubMed CAS Google Scholar
Mubeen S, Gibson C, Mubeen R, Mansour S, Evans RD. SHORT syndrome: systematic appraisal of the medical and dental phenotype. Cleft Palate Craniofac J. 2021;2:10556656211026860. A recent update on the clinical phenotype of this rare disorder.
Kim S-H, Kim M, Yim J, Kim M, Jang D-H. Transient neonatal diabetes mellitus in SHORT syndrome: a case report. Front Pediatr. 2021;23:9.
Marzollo A, Maestrini G, La Starza R, Elia L, Malfona F, Pierini T, Tretti Parenzan C, Coppe A, Bortoluzzi S, Biffi A, Mecucci C, Bresolin S, Testi AM. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell acute lymphoblastic leukemia. Am J Hematol. 2020;95(12):E335–8.
Article PubMed CAS Google Scholar
Petrovski S, Parrott RE, Roberts JL, Huang H, Yang J, Gorentla B, et al. Dominant splice site mutations in PIK3R1 cause hyper IgM syndrome, lymphadenopathy and short stature. J Clin Immunol. 2016;36(5):462–71.
Article PubMed PubMed Central CAS Google Scholar
Bravo García-Morato M, García-Miñaúr S, Molina Garicano J, Santos Simarro F, Del Pino Molina L, López-Granados E, et al. Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two. Clin Immunol. 2017;179:77–80.
Reardon W, Temple IK. Nephrocalcinosis and disordered calcium metabolism in two children with SHORT syndrome. Am J Med Genet A. 2008;146A(10):1296–8.
Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009;119(2):315–22.
PubMed PubMed Central CAS Google Scholar
Semple RK, Williams RM, Dunger DB. What is the best management strategy for patients with severe insulin resistance? Clin Endocrinol (Oxf). 2010;73(3):286–90.
Jakubowicz D, Wainstein J, Ahrén B, Bar-Dayan Y, Landau Z, Rabinovitz HR, et al. High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial. Diabetologia. 2015;58(5):912–9.
Article PubMed CAS Google Scholar
Hamaguchi T, Hirota Y, Takeuchi T, Nakagawa Y, Matsuoka A, Matsumoto M, et al. Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor. J Diabetes Investig. 2018;9(5):1224–7.
Article PubMed PubMed Central CAS Google Scholar
Masunaga Y, Fujisawa Y, Muramatsu M, Ono H, Inoue T, Fukami M, et al. Insulin resistant diabetes mellitus in SHORT syndrome: case report and literature review. Endocr J. 2021;68(1):111–7.
Yin X, Liu J, Feng R, Xu M, Liu J. Novel PIK3R1 mutation of SHORT syndrome: a case report with a 6-month follow up. J Diabetes Investig. 2021;12(10):1919–22.
Article PubMed PubMed Central CAS Google Scholar
Lewandowski KC, Dąbrowska K, Brzozowska M, Kawalec J, Lewiński A. Metformin paradoxically worsens insulin resistance in SHORT syndrome. Diabetol Metab Syndr. 2019;1(11):81.
Zhang Y, Ji B, Li J, Li Y, Zhang M, Ban B. SHORT syndrome in two Chinese girls: a case report and review of the literature. Mol Genet Genomic Med. 2020;8(9):e1385.
Article PubMed PubMed Central Google Scholar
Kaneto H, Kimura T, Obata A, Shimoda M, Kaku K. Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history. Int J Mol Sci. 2021;22(5).
留言 (0)